Loading…
Employees: 3,578
Size China Isotope & Radiation (1763.HK) is a Hong Kong Health Care company (Medical Specialties) with a market value of $478M, the 762nd largest of 891 Hong Kong companies the cockpit tracks. Shares closed at HK$11.72 on 6 Nov 2026.
Performance Over six months the shares fell 38.3%, against -13.4% for the median peer and -13.4% for the Hong Kong market (cap-weighted) — lowest of 21 in its peer set.
Growth Revenue fell 5.1% over the last twelve months (peer median +1.2%); the operating margin is 13.1% (peer median 6.3%).
Valuation It trades at 6.7× forward earnings against a peer median of 22.6× (cheapest of 11).
Next results Next results expected around 31 Mar 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | n/a | HK$7.80B | HK$8.21B | HK$7.33B | HK$7.16B |
| Revenue growth | — | -5% | +12% | +2% | — |
| Gross profit | n/a | HK$3.90B | HK$3.99B | HK$3.84B | HK$4.09B |
| EBITDA | n/a | HK$1.30B | HK$1.35B | HK$1.06B | HK$1.21B |
| Net income | n/a | HK$355M | HK$441M | HK$410M | HK$456M |
| Free cash flow | n/a | -HK$53.9M | -HK$1.00B | -HK$836M | HK$425M |
| Capital expenditure | n/a | HK$615M | HK$1.12B | HK$992M | HK$670M |
| Total debt | n/a | HK$3.12B | HK$2.79B | HK$1.94B | HK$1.06B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 1763.HK | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -10.0% | -4.6% | 6th lowest of 21 |
| 6-month return | -38.3% | -13.4% | lowest of 21 |
| Distance from 52-week high | -53.1% | -34.5% | 4th lowest of 21 |
| Revenue growth (TTM) | -5.1% | +1.2% | 6th lowest of 21 |
| Operating margin | 13.1% | 6.3% | 7th highest of 21 |
| Forward P/E | 6.7× | 22.6× | cheapest of 11 |
| Net debt / EBITDA | 0.2× | -1.6× | 3rd most indebted of 8 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| China Isotope & Radiation 1763.HK | Hong Kong | $478M | -38% | -5% | 13% | 6.7× | n/a | n/a |
| Shofu 7979.T | Japan | $475M | +27% | +7% | 14% | 12.2× | n/a | n/a |
| Beijing Leadman Biochemistry 300289.SZ | China | $483M | -11% | -6% | -12% | n/a | 35.5% | -6.9% |
| Shanghai Kindly Enterprises Development 603987.SS | China | $474M | -14% | 0% | 11% | n/a | 3.8% | -2.8% |
| MiMedx MDXG | United States | $483M | -8% | -23% | -8% | 59.1× | 11.5% | +11.0% |
| Guangdong Shirongzhaoye 002016.SZ | China | $473M | -28% | -31% | 3% | n/a | 22.2% | -11.7% |
| Huaren Pharmaceutical 300110.SZ | China | $472M | -16% | -3% | 6% | n/a | 6.7% | +0.3% |
| CellaVision CEVI.ST | Sweden | $485M | +68% | +2% | 23% | 31.8× | 6.5% | +10.0% |
| Guangzhou Jet Bio-Filtration 688026.SS | China | $471M | +40% | +5% | 11% | 38.6× | 22.1% | +2.2% |
| WELL LEAD MEDICAL 603309.SS | China | $486M | -19% | +1% | 15% | 12.2× | -5.6% | +7.7% |
| Jiangsu Huayang Intelligent Equipment 301502.SZ | China | $470M | +35% | -5% | 2% | n/a | 42.6% | +0.4% |
| AngioDynamics ANGO | United States | $493M | +5% | +8% | -6% | n/a | n/a | n/a |
| Jenscare Scientific 9877.HK | Hong Kong | $463M | -32% | +993% | -106% | n/a | n/a | n/a |
| Revenio REG1V.HE | Finland | $494M | -22% | +16% | 14% | 18.5× | 19.3% | +12.4% |
| Wuhan Easy Diagnosis Biomedicine 002932.SZ | China | $499M | -14% | -9% | -51% | n/a | n/a | n/a |
| Eiken Chemical 4549.T | Japan | $454M | -29% | +4% | 6% | 23.6× | n/a | n/a |
| Hunan Sundy Science and Technology 300515.SZ | China | $453M | -13% | +10% | 27% | 14.1× | 0.9% | +15.6% |
| PROTEINA 468530.KS | South Korea | $450M | -2% | -59% | -1,178% | n/a | n/a | n/a |
| Brainsway Ltd Sponsored ADR BWAY | United States | $450M | -35% | +32% | 12% | 27.4× | 34.3% | +18.8% |
| AVITA Medical RCEL | United States | $513M | +304% | +1% | -47% | n/a | n/a | n/a |
| Chison Medical Technologies 688358.SS | China | $443M | -16% | -1% | 19% | 21.6× | 11.8% | +5.6% |